Literature DB >> 30227910

Contraception after Abortion and Risk of Repeated Unintended Pregnancy among Health Plan Members.

Debbie Postlethwaite1, Justine Lee2, Maqdooda Merchant3, Amy Alabaster4, Tina Raine-Bennett5.   

Abstract

CONTEXT: Optimizing access to effective contraception at the time of abortion can reduce repeated unintended pregnancies.
OBJECTIVE: To assess contraception initiation and repeated unintended pregnancies among women receiving abortions in Kaiser Permanente Northern California (KPNC) facilities and through outside contracted facilities.
DESIGN: A retrospective cohort study was conducted using a randomized proportional sample of women aged 15 to 44 years having abortions in KPNC, to determine contraception initiation within 90 days. Demographic and clinical characteristics (age, race/ethnicity, gravidity, parity, contraceptive method initiated, and pregnancies within 12 months) were collected from electronic health records. Descriptive statistics, χ2 tests, t-tests, and logistic regression models assessed predictors of long-acting reversible contraception (LARC) initiation and having another unintended pregnancy within 12 months of abortion.
RESULTS: Women having abortions from contracted facilities were significantly less likely to initiate LARC within 90 days compared with those receiving abortions in KPNC facilities (11.99% vs 19.10%, p = 0.012). Significant factors associated with 90-day LARC initiation included abortions in KPNC facilities (adjusted odds ratio [aOR] = 1.87, p = 0.007) and gravidity of 3 or more. Women initiating short-acting or no contraception were significantly more likely to have an unintended pregnancy within 12 months of the abortion than those initiating LARC (aOR = 3.66, p = 0.005; no contraception vs LARC, aOR = 3.75, p = 0.005).
CONCLUSION: In response to this study, KPNC now provides reimbursement for LARC in all outside abortion contracts, internalized more abortions in KPNC facilities, and strengthened clinical recommendations for immediate, effective postabortion contraception, especially LARC.

Entities:  

Mesh:

Year:  2018        PMID: 30227910      PMCID: PMC6141650          DOI: 10.7812/TPP/18-058

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  18 in total

1.  Comparison of contraceptive method chosen by women with and without a recent history of induced abortion.

Authors:  Tessa Madden; Gina M Secura; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Contraception       Date:  2011-05-04       Impact factor: 3.375

2.  Contraceptive discontinuation and repeat unintended pregnancy within 1 year after an abortion.

Authors:  Ushma D Upadhyay; Beth A Brown; Abby Sokoloff; Tina R Raine
Journal:  Contraception       Date:  2011-06-30       Impact factor: 3.375

3.  Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.

Authors:  Heather L Hohmann; Matthew F Reeves; Beatrice A Chen; Lisa K Perriera; Jennifer L Hayes; Mitchell D Creinin
Journal:  Contraception       Date:  2011-09-13       Impact factor: 3.375

4.  Preventing repeat abortion in Canada: is the immediate insertion of intrauterine devices postabortion a cost-effective option associated with fewer repeat abortions?

Authors:  Christina M Ames; Wendy V Norman
Journal:  Contraception       Date:  2011-07-20       Impact factor: 3.375

5.  Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.

Authors:  Sally B Rose; Susan M Garrett; James Stanley
Journal:  Contraception       Date:  2015-03-27       Impact factor: 3.375

6.  Impact of long-acting reversible contraception on return for repeat abortion.

Authors:  Sally B Rose; Beverley A Lawton
Journal:  Am J Obstet Gynecol       Date:  2011-07-13       Impact factor: 8.661

7.  Intra-abortion contraception with etonogestrel subdermal implant.

Authors:  Isabel Barros Pereira; Rui M Carvalho; Luís M Graça
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2014-11-29       Impact factor: 2.435

8.  Ovulation resumption after medical abortion with mifepristone and misoprostol.

Authors:  Courtney A Schreiber; Stephanie Sober; Sarah Ratcliffe; Mitchell D Creinin
Journal:  Contraception       Date:  2011-02-24       Impact factor: 3.375

9.  Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion.

Authors:  Ann M Stanek; Paula H Bednarek; Mark D Nichols; Jeffrey T Jensen; Alison B Edelman
Journal:  Contraception       Date:  2008-10-22       Impact factor: 3.375

10.  Increasing intrauterine contraception use by reducing barriers to post-abortal and interval insertion.

Authors:  Suzan Goodman; Sarah K Hendlish; Courtney Benedict; Matthew F Reeves; Madeline Pera-Floyd; Anne Foster-Rosales
Journal:  Contraception       Date:  2008-06-18       Impact factor: 3.375

View more
  1 in total

1.  Prevalence and Predictors of Contraceptives Use among Women Aged (15-49 years) with Induced Abortion History in Ghana.

Authors:  Mohammed Gazali Salifu; Kamaldeen Mohammed
Journal:  Adv Prev Med       Date:  2020-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.